HOME >> BIOLOGY >> NEWS
New Machine Slashes Time, Cost To Make Unique Lenses

Engineers from the University of Rochester and seven corporate partners, working with the U.S. Department of Defense's Advanced Research Projects Agency (DARPA), have developed the first system to automate the manufacture of unusually shaped lenses known as aspheres. Officials at the University's Center for Optics Manufacturing (COM) say the machine is capable of producing these aspheric lenses in minutes, not days, at a fraction of the current cost.

Its developers say the savings in time and money should trickle down to products ranging from 35-millimeter cameras and medical endoscopes to military-grade night-vision goggles. High costs -- up to $4,000 for a meticulously formed, doorknob-sized piece of glass -- have limited the use of aspheres, despite their ability to deliver much better optical performance and image quality than traditional spherical lenses. The new asphere machining system greatly streamlines production; engineers believe the machine will push costs down to as little as $25 to $100 per lens.

"There isn't an optical device around that wouldn't benefit from aspheres," says Harvey Pollicove, director of COM, which is now testing the new machine. "Aspheres are used in nearly every application for which they're affordable, and every engineer who designs optical devices wants to use them."

Aspheres are well suited for a wide range of consumer goods, including compact disk players, photocopiers, and projection televisions; top-rated cameras and video camcorders now rely on three or four aspheres to achieve lightweight, compact designs with improved image quality. Beyond the consumer realm, aspheres are also used in virtual reality helmets, professional-quality movie cameras, surgical lasers, bar-code laser scanners, and in endoscopes to see inside the body. The new machine might also provide a cheaper way to produce aspheric elements that are found in the $500,000 lenses now used to make computer chips by tracing out integrat
'"/>

Contact: Steve Bradt
sbradt@admin.rochester.edu
716-273-4726
University of Rochester
7-May-1998


Page: 1 2 3 4

Related biology news :

1. Darwins Time Machine: Scientists begin predicting evolutions next step
2. Porous Silicon Joining Humans To Machines
3. Whitehead Receives $7 million NIH Grant To Build High-Speed Sequencing Machines
4. New Insights Into The Transport Machinery Of The Cell: A Single Protein Substitutes The Regulatory Machinery Specifying Endosome Fusion In Vitro
5. NIST Machine To Aid In Making Better Artificial Joints
6. Crystal Structure Of The Archaeal Chaperonin Thermosome, A Protein-Folding Machine, Determined
7. Prostate Cancer Switch May Yield Map Of Cancer Machinery, Targets For Drugs
8. Insights Into The Proteasome - A Fascinating Macromolecular Machine For Protein Degradation
9. Cooking And Salad Oils Could Lubricate Cars, Boats, Machines
10. Unique partnership between UH, FDA opens path for scientific exchange
11. Unique two-part macroemulsion offers new approach to cleaning up contaminated aquifers

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New Machine Slashes Time Cost Make Unique Lenses

(Date:6/18/2015)... 18, 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... the growing mobile commerce market announces that its Wocket® smart ... "Money on the Mark", scheduled to air on WABC Radio ... 20 th . The broadcast air- time ... to 8:00pm EST. NXT-ID, Inc.,s CEO Gino Pereira ...
(Date:6/17/2015)... GARDENS, Fla. , June 17, 2015 /PRNewswire/ ... solutions, today announced that its U.are.U ® ... Togo,s Eateries, Inc., a ... casual sandwich chain, to increase security, improve accountability ... fingerprint readers enable instant, non-repudiable identity confirmation for ...
(Date:6/16/2015)... Sweden , June 16, 2015 ... from previously communicated that it will amount to at least ... MSEK. Due to the rapid increase in market growth and ... the previously communicated guidance that revenue for 2015 will exceed ... will amount to approximately 2,200 MSEK. Due to ...
Breaking Biology News(10 mins):NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 2NXT-ID, Inc.'s CEO Gino Pereira Talks About the Wocket Smart Wallet on WABC Radio, New York City, June 20th 3Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 2Togo's Eateries Improve Security and Accountability with Crossmatch Fingerprint Readers 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3
(Date:6/30/2015)... BOSTON , June 30, 2015  Juniper ... company focused on developing therapeutics that address unmet ... CFO George Elston will present at ... , Wednesday, July 8, 2015Time: , 4:45 PM ... NYWebcast (live & archive): , www.juniperpharma.com, under  ...
(Date:6/30/2015)... ... June 30, 2015 , ... With its latest polyacrylonitrile ... to achieve faster flow rates in comparison to nylon or polyethersulfone (PES). ... to allow easy liquid flow while trapping particulates as small as 0.2 micron ...
(Date:6/30/2015)... , ... June 30, 2015 , ... Matrix Marketing ... that it has hired Gem Swartz to head up its account management department as ... director. Both Gem and Amanda bring senior account management and delivery expertise to the ...
(Date:6/30/2015)... , June 30, 2015 /PRNewswire/ - RepliCel Life ... stage regenerative medicine company focused on the development ... participant in its Phase 1/2 clinical trial of ... unilateral Achilles tendinosis, has been enrolled and their ... ultrasound-guided injections. RCT-01 is comprised of non-bulbar dermal ...
Breaking Biology Technology:Juniper Pharmaceuticals to Present at Cantor Fitzgerald Inaugural Healthcare Conference on July 8, 2015 2New Nanofiber Membrane Provides Fast, Efficient Filtration 2Matrix Marketing Group Expands Client Services Team 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 2RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 3RepliCel Life Sciences Enrolls First Participant in Phase 1/2 Clinical Trial of RCT-01 for Chronic Achilles Tendinosis 4
Cached News: